|
gptkbp:instanceOf
|
gptkb:benzodiazepine
|
|
gptkbp:ATCCode
|
N05BA03
|
|
gptkbp:brand
|
Azepamid
Nobrium
Rudotel
|
|
gptkbp:CASNumber
|
2898-12-6
|
|
gptkbp:category
|
gptkb:recreational_drug
gptkb:sedative
gptkb:muscle_relaxant
gptkb:hypnotic
gptkb:prodrug
gptkb:anticonvulsant
lactam
chlorobenzene derivative
|
|
gptkbp:chemicalFormula
|
C16H15ClN2
|
|
gptkbp:contraindication
|
gptkb:myasthenia_gravis
severe respiratory insufficiency
sleep apnea syndrome
severe hepatic insufficiency
|
|
gptkbp:discoveredBy
|
1965
|
|
gptkbp:eliminationHalfLife
|
36–150 hours
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
GABA-A receptor positive allosteric modulator
|
|
gptkbp:meltingPoint
|
104–105 °C
|
|
gptkbp:metabolism
|
gptkb:diazepam
gptkb:oxazepam
gptkb:temazepam
nordazepam
|
|
gptkbp:molecularWeight
|
270.76 g/mol
|
|
gptkbp:pregnancyCategory
|
D (US)
|
|
gptkbp:PubChem_CID
|
4167
4023
1201242
DB01581
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
confusion
muscle weakness
drowsiness
ataxia
dependence
|
|
gptkbp:synonym
|
7-chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepine
|
|
gptkbp:UNII
|
U7A1V1S8G3
|
|
gptkbp:usedFor
|
insomnia
anxiety disorders
muscle spasms
|
|
gptkbp:bfsParent
|
gptkb:N05BA
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Medazepam
|